Literature DB >> 20149745

Good cells gone bad: the cellular origins of cancer.

Jean C Y Wang1.   

Abstract

One issue in human cancer research that remains largely unresolved is the identity of the normal cell type in which tumorigenesis begins. Knowledge of the starting cell populations targeted by transforming events is crucial for characterizing early neoplastic changes and understanding how normal cellular processes become disrupted during cancer development. Recent focus on cancer stem cells (CSCs) has been accompanied by the frequent assumption that these cells derive from normal stem cells. However, evidence from mouse tumor models has demonstrated that cancer can also arise from committed progenitors. This review highlights recent insights gained from studies of the normal cell populations targeted for malignant transformation - in other words, the cellular origins of cancer. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149745     DOI: 10.1016/j.molmed.2010.01.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  18 in total

Review 1.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

2.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

3.  Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.

Authors:  Ntube N O Ngalame; Ngome L Makia; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-22       Impact factor: 4.219

4.  Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.

Authors:  M Orciani; S Davis; G Appolloni; R Lazzarini; M Mattioli-Belmonte; R A Ricciuti; M Boscaro; R Di Primio; G Arnaldi
Journal:  Cancer Gene Ther       Date:  2014-12-19       Impact factor: 5.987

5.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

Review 6.  From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer.

Authors:  Benjamin Tiede; Yibin Kang
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

Review 7.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

8.  Isolation and Separation of Epithelial CD34+ Cancer Stem Cells from Tgfbr2-deficient Squamous Cell Carcinoma.

Authors:  Heather A McCauley; Géraldine Guasch
Journal:  Bio Protoc       Date:  2017-09-05

9.  Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.

Authors:  Ntube N O Ngalame; Anthony L Luz; Ngome Makia; Erik J Tokar
Journal:  Toxicol Sci       Date:  2018-09-01       Impact factor: 4.849

10.  CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.

Authors:  Wei Huang; Jingyao Zhang; Miaomiao Huo; Jie Gao; Tianshu Yang; Xin Yin; Pei Wang; Shuai Leng; Dandan Feng; Yang Chen; Yang Yang; Yan Wang
Journal:  Adv Sci (Weinh)       Date:  2021-03-16       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.